Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,735
archived clinical trials in
Psoriasis

Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Efficacy and Long-Term Safety of Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated:  10/12/2017
Clinical Research Facility
2469
mi
from 91732
South Burlington, VT
Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Efficacy and Long-Term Safety of Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
2469
mi
from 91732
South Burlington, VT
Click here to add this to my saved trials
Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Efficacy and Long-Term Safety of Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated:  10/12/2017
Clinical Research Facility
2269
mi
from 91732
Henrico, VA
Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Efficacy and Long-Term Safety of Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
2269
mi
from 91732
Henrico, VA
Click here to add this to my saved trials
Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Efficacy and Long-Term Safety of Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated:  10/12/2017
Clinical Research Facility
2336
mi
from 91732
Norfolk, VA
Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Efficacy and Long-Term Safety of Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
2336
mi
from 91732
Norfolk, VA
Click here to add this to my saved trials
Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Efficacy and Long-Term Safety of Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated:  10/12/2017
Clinical Research Facility
2267
mi
from 91732
Richmond, VA
Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Efficacy and Long-Term Safety of Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
2267
mi
from 91732
Richmond, VA
Click here to add this to my saved trials
Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Efficacy and Long-Term Safety of Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated:  10/12/2017
Clinical Research Facility
939
mi
from 91732
Spokane, WA
Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Efficacy and Long-Term Safety of Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
939
mi
from 91732
Spokane, WA
Click here to add this to my saved trials
Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Efficacy and Long-Term Safety of Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated:  10/12/2017
Clinical Research Facility
1573
mi
from 91732
Saint Louis, MO
Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Efficacy and Long-Term Safety of Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 10/12/2017
Clinical Research Facility
1573
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
Comparative Effectiveness of Psoriasis Treatments on Systemic Inflammation
Comparative Effectiveness of Psoriasis Treatments on Systemic Inflammation
Status: Enrolling
Updated:  10/12/2017
University Hospitals of Cleveland Medical Center
2032
mi
from 91732
Cleveland, OH
Comparative Effectiveness of Psoriasis Treatments on Systemic Inflammation
Comparative Effectiveness of Psoriasis Treatments on Systemic Inflammation
Status: Enrolling
Updated: 10/12/2017
University Hospitals of Cleveland Medical Center
2032
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Micro-Technique Sampling
An Exploratory Comparative Pilot Study to Identify the Most Appropriate Method for Microbial Consortia Sampling From the Skin-II
Status: Enrolling
Updated:  10/30/2017
Reliance Clinical Testing Services, Inc.
1215
mi
from 91732
Irving, TX
Micro-Technique Sampling
An Exploratory Comparative Pilot Study to Identify the Most Appropriate Method for Microbial Consortia Sampling From the Skin-II
Status: Enrolling
Updated: 10/30/2017
Reliance Clinical Testing Services, Inc.
1215
mi
from 91732
Irving, TX
Click here to add this to my saved trials
Prevalence of Sleep Disturbances in Psoriasis
Prevalence of Sleep Disturbances in Psoriasis
Status: Enrolling
Updated:  11/1/2017
Wake Forest University Health Sciences, Dermatology
2129
mi
from 91732
Winston-Salem, NC
Prevalence of Sleep Disturbances in Psoriasis
Prevalence of Sleep Disturbances in Psoriasis
Status: Enrolling
Updated: 11/1/2017
Wake Forest University Health Sciences, Dermatology
2129
mi
from 91732
Winston-Salem, NC
Click here to add this to my saved trials
Using an Internet Study to Improve Adherence for Psoriasis Patients
Using an Internet Study to Improve Adherence for Psoriasis Patients
Status: Enrolling
Updated:  11/1/2017
Wake Forest School of Medicine - Dermatology Clinic
2125
mi
from 91732
Winston-Salem, NC
Using an Internet Study to Improve Adherence for Psoriasis Patients
Using an Internet Study to Improve Adherence for Psoriasis Patients
Status: Enrolling
Updated: 11/1/2017
Wake Forest School of Medicine - Dermatology Clinic
2125
mi
from 91732
Winston-Salem, NC
Click here to add this to my saved trials
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  11/1/2017
GSK Investigational Site
2321
mi
from 91732
Miami, FL
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 11/1/2017
GSK Investigational Site
2321
mi
from 91732
Miami, FL
Click here to add this to my saved trials
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  11/1/2017
GSK Investigational Site
1813
mi
from 91732
Louisville, KY
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 11/1/2017
GSK Investigational Site
1813
mi
from 91732
Louisville, KY
Click here to add this to my saved trials
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  11/1/2017
GSK Investigational Site
1357
mi
from 91732
Houston, TX
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 11/1/2017
GSK Investigational Site
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  11/1/2017
GSK Investigational Site
1184
mi
from 91732
San Antonio, TX
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 11/1/2017
GSK Investigational Site
1184
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  11/1/2017
GSK Investigational Site
99
mi
from 91732
San Diego, CA
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 11/1/2017
GSK Investigational Site
99
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  11/1/2017
GSK Investigational Site
mi
from 91732
North Logan, CT
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 11/1/2017
GSK Investigational Site
mi
from 91732
North Logan, CT
Click here to add this to my saved trials
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  11/1/2017
GSK Investigational Site
1730
mi
from 91732
Chicago, IL
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 11/1/2017
GSK Investigational Site
1730
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  11/1/2017
GSK Investigational Site
1779
mi
from 91732
Plainfield, IN
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 11/1/2017
GSK Investigational Site
1779
mi
from 91732
Plainfield, IN
Click here to add this to my saved trials
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  11/1/2017
GSK Investigational Site
1333
mi
from 91732
Overland Park, KA
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 11/1/2017
GSK Investigational Site
1333
mi
from 91732
Overland Park, KA
Click here to add this to my saved trials
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  11/1/2017
GSK Investigational Site
2138
mi
from 91732
High Point, NC
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 11/1/2017
GSK Investigational Site
2138
mi
from 91732
High Point, NC
Click here to add this to my saved trials
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  11/1/2017
GSK Investigational Site
2373
mi
from 91732
Philadelphia, PA
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 11/1/2017
GSK Investigational Site
2373
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  11/1/2017
GSK Investigational Site
2121
mi
from 91732
Pittsburgh, PA
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 11/1/2017
GSK Investigational Site
2121
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  11/1/2017
GSK Investigational Site
2557
mi
from 91732
Johnston, RI
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 11/1/2017
GSK Investigational Site
2557
mi
from 91732
Johnston, RI
Click here to add this to my saved trials
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  11/1/2017
GSK Investigational Site
1766
mi
from 91732
Goodlettsville, TN
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 11/1/2017
GSK Investigational Site
1766
mi
from 91732
Goodlettsville, TN
Click here to add this to my saved trials
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  11/1/2017
GSK Investigational Site
1211
mi
from 91732
Austin, TX
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 11/1/2017
GSK Investigational Site
1211
mi
from 91732
Austin, TX
Click here to add this to my saved trials
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  11/1/2017
GSK Investigational Site
1337
mi
from 91732
Webster, TX
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 11/1/2017
GSK Investigational Site
1337
mi
from 91732
Webster, TX
Click here to add this to my saved trials
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  11/1/2017
GSK Investigational Site
963
mi
from 91732
Seattle, WA
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 11/1/2017
GSK Investigational Site
963
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  11/1/2017
GSK Investigational Site
mi
from 91732
Surrey,
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 11/1/2017
GSK Investigational Site
mi
from 91732
Surrey,
Click here to add this to my saved trials
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  11/1/2017
GSK Investigational Site
1999
mi
from 91732
Fort Gratiot Township, MI
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 11/1/2017
GSK Investigational Site
1999
mi
from 91732
Fort Gratiot Township, MI
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis
Status: Enrolling
Updated:  11/2/2017
Abbvie Clinical Pharmacology Research Unit /ID# 163866
1715
mi
from 91732
Grayslake, IL
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis
Status: Enrolling
Updated: 11/2/2017
Abbvie Clinical Pharmacology Research Unit /ID# 163866
1715
mi
from 91732
Grayslake, IL
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis
Status: Enrolling
Updated:  11/2/2017
Anaheim Clinical Trials LLC /ID# 164101
16
mi
from 91732
Anaheim, CA
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis
Status: Enrolling
Updated: 11/2/2017
Anaheim Clinical Trials LLC /ID# 164101
16
mi
from 91732
Anaheim, CA
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis
Status: Enrolling
Updated:  11/2/2017
Progressive Medical Research /ID# 163868
2193
mi
from 91732
Port Orange, FL
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis
Status: Enrolling
Updated: 11/2/2017
Progressive Medical Research /ID# 163868
2193
mi
from 91732
Port Orange, FL
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis
Status: Enrolling
Updated:  11/2/2017
Providence Clinical Research /ID# 163867
23
mi
from 91732
Toluca, CA
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis
Status: Enrolling
Updated: 11/2/2017
Providence Clinical Research /ID# 163867
23
mi
from 91732
Toluca, CA
Click here to add this to my saved trials
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated:  11/17/2017
Rheumatology Associates, PC
1785
mi
from 91732
Birmingham, AL
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated: 11/17/2017
Rheumatology Associates, PC
1785
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated:  11/17/2017
Arizona Arthritis and Rheumatology Research
336
mi
from 91732
Glendale, AZ
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated: 11/17/2017
Arizona Arthritis and Rheumatology Research
336
mi
from 91732
Glendale, AZ
Click here to add this to my saved trials
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated:  11/17/2017
Arizona Arthritis & Rheumatology Associates, P. C.
355
mi
from 91732
Mesa, AZ
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated: 11/17/2017
Arizona Arthritis & Rheumatology Associates, P. C.
355
mi
from 91732
Mesa, AZ
Click here to add this to my saved trials
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated:  11/17/2017
Arizona Arthritis Research PLC
345
mi
from 91732
Phoenix, AZ
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated: 11/17/2017
Arizona Arthritis Research PLC
345
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated:  11/17/2017
Little Rock Diagnostic Clinic
1460
mi
from 91732
Little Rock, AR
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated: 11/17/2017
Little Rock Diagnostic Clinic
1460
mi
from 91732
Little Rock, AR
Click here to add this to my saved trials
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated:  11/17/2017
The University of California, San Diego
95
mi
from 91732
La Jolla, CA
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated: 11/17/2017
The University of California, San Diego
95
mi
from 91732
La Jolla, CA
Click here to add this to my saved trials
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated:  11/17/2017
Purushotham & Akther Kotha MD Inc
106
mi
from 91732
LA Mesa, CA
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated: 11/17/2017
Purushotham & Akther Kotha MD Inc
106
mi
from 91732
LA Mesa, CA
Click here to add this to my saved trials
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated:  11/17/2017
Stanford University Hospital
328
mi
from 91732
Palo Alto, CA
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated: 11/17/2017
Stanford University Hospital
328
mi
from 91732
Palo Alto, CA
Click here to add this to my saved trials
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated:  11/17/2017
East Bay Rheumatology Medical Group, Inc.
340
mi
from 91732
San Leandro, CA
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated: 11/17/2017
East Bay Rheumatology Medical Group, Inc.
340
mi
from 91732
San Leandro, CA
Click here to add this to my saved trials
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated:  11/17/2017
Office: Dr Robin K Dore
25
mi
from 91732
Tustin, CA
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated: 11/17/2017
Office: Dr Robin K Dore
25
mi
from 91732
Tustin, CA
Click here to add this to my saved trials
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated:  11/17/2017
Rheumatology Associates of South Florida
2311
mi
from 91732
Boca Raton, FL
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated: 11/17/2017
Rheumatology Associates of South Florida
2311
mi
from 91732
Boca Raton, FL
Click here to add this to my saved trials
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated:  11/17/2017
Jeffrey Alper, MD Research
2220
mi
from 91732
Naples, FL
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated: 11/17/2017
Jeffrey Alper, MD Research
2220
mi
from 91732
Naples, FL
Click here to add this to my saved trials
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated:  11/17/2017
Arthritis & osteoporosis treatment center,PA
2130
mi
from 91732
Orange Park, FL
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated: 11/17/2017
Arthritis & osteoporosis treatment center,PA
2130
mi
from 91732
Orange Park, FL
Click here to add this to my saved trials
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated:  11/17/2017
Gulf Clinical Research Institute
1808
mi
from 91732
Pensacola, FL
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated: 11/17/2017
Gulf Clinical Research Institute
1808
mi
from 91732
Pensacola, FL
Click here to add this to my saved trials
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated:  11/17/2017
Diagnostic Rheumatology and Research PC
1793
mi
from 91732
Indianapolis, IN
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated: 11/17/2017
Diagnostic Rheumatology and Research PC
1793
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated:  11/17/2017
Physician's Clinic of Iowa, P.C.
1526
mi
from 91732
Cedar Rapids, IA
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated: 11/17/2017
Physician's Clinic of Iowa, P.C.
1526
mi
from 91732
Cedar Rapids, IA
Click here to add this to my saved trials
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated:  11/17/2017
Heartland Research Associates, LLC
1186
mi
from 91732
Wichita, KA
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Multicenter, Randomized, Double-Blind, Placebo Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Experienced Patients With Active Psoriatic Arthritis
Status: Enrolling
Updated: 11/17/2017
Heartland Research Associates, LLC
1186
mi
from 91732
Wichita, KA
Click here to add this to my saved trials